Published in Am J Pathol on March 01, 1995
Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol (2011) 0.83
Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis. Rheumatol Int (2003) 0.77
Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Matrix Biol (2016) 0.76
Unchanged distribution density of anionic sites on the glomerular wall in rats with active heymann nephritis. J Toxicol Pathol (2013) 0.75
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79
Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol (1982) 9.73
Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol (1980) 2.75
Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest (1986) 2.00
Investigations of avidin and biotin for imaging applications. J Nucl Med (1987) 1.88
Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today (1990) 1.84
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69
Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum (1990) 1.60
Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest (1994) 1.54
Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med (1989) 1.48
Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci U S A (1983) 1.35
Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol (1991) 1.30
Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes. Am J Pathol (1985) 1.26
Glomerular permeability: transfer of native ferritin in glomeruli with decreased anionic sites. Lab Invest (1978) 1.26
Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int (1992) 1.24
Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes (1982) 1.22
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest (1982) 1.10
Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase. Virchows Arch A Pathol Anat Histopathol (1985) 1.09
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat. Kidney Int (1982) 1.04
Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem (1994) 1.04
Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int (1981) 1.04
Decreased anionic groups and increased permeability precedes deposition of immune complexes in the glomerular capillary wall. Am J Pathol (1981) 1.04
Localization of neutrophil cationic proteins and loss of anionic charges in glomeruli of patients with systemic lupus erythematosus glomerulonephritis. Clin Immunol Immunopathol (1982) 1.03
Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes (1987) 1.01
Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice. J Biol Chem (1983) 1.00
Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin Exp Immunol (1990) 0.98
Glomerular immune deposits in murine lupus models may contain histones. Clin Exp Immunol (1992) 0.98
Glomerular permeability: focal loss of anionic sites in glomeruli of proteinuric mice with lupus nephritis. Lab Invest (1980) 0.97
Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane. Biochem J (1989) 0.93
Improved method for the isolation of mouse glomeruli. J Am Soc Nephrol (1991) 0.90
Platelet cationic proteins are present in glomeruli of lupus nephritis patients. Kidney Int (1986) 0.87
Changes in heparan sulfate correlate with increased glomerular permeability. Kidney Int (1988) 0.85
Anionic sites and the mechanisms of proteinuria. N Engl J Med (1983) 0.85
Composition of immune deposits present in glomeruli of NZB/W F1 mice. Clin Immunol Immunopathol (1991) 0.85
A role for histones and ubiquitin in lupus nephritis? Clin Nephrol (1994) 0.85
Glomerular albumin leakage and morphology after neutralization of polyanions. II. Discrepancy of protamine induced albuminuria and fine structure of the glomerular filtration barrier. J Submicrosc Cytol (1984) 0.84
Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis. Clin Exp Immunol (1993) 0.84
Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis. Lab Invest (1992) 0.82
Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus. Autoimmunity (1991) 0.81
Effect of diabetes on in vivo metabolism of [35S]-labeled glomerular basement membrane. Diabetes (1984) 0.81
Glomerular albumin leakage and morphology after neutralization of polyanions. I. Albumin clearance and sieving coefficient in the isolated perfused rat kidney. Ren Physiol (1984) 0.80
Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem (1994) 0.79
Murine lupus nephritis. Effects of glucocorticoid on glomerular permeability. Lab Invest (1984) 0.76
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum (2000) 6.46
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med (1995) 2.98
Reactive arthritis associated with Campylobacter jejuni enteritis. Br Med J (1979) 2.46
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol Dial Transplant (2011) 2.04
Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest (1986) 2.00
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int (2006) 1.92
Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today (1990) 1.84
Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J Immunol (1983) 1.81
Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. J Rheumatol (1992) 1.79
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69
The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55
Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest (1994) 1.54
Systemic lupus erythematosus after renal transplantation: patient and graft survival and disease activity. The Dutch Working Party on Systemic Lupus Erythematosus. Ann Intern Med (1991) 1.51
Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin. J Pathol (1997) 1.50
Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy (2005) 1.44
Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol (1985) 1.44
Characterization of the autoantigen calreticulin. J Immunol (1991) 1.42
Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study. Diabetologia (1994) 1.41
Sjögren's syndrome complicated by cryoglobulinaemia and acute renal failure. Neth J Med (1991) 1.40
[Immunology in medical practice. XXI. Laboratory tests for immunologic diseases]. Ned Tijdschr Geneeskd (1999) 1.39
A sporadic case of acute Hantavirus nephropathy in The Netherlands. Neth J Med (1989) 1.38
Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol (1996) 1.37
Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int (2000) 1.37
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35
Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol (1989) 1.26
Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Histochem Cytochem (1996) 1.25
Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem (1997) 1.24
Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int (1992) 1.24
Identification of the endothelial cell binding site for factor IX. Proc Natl Acad Sci U S A (1996) 1.21
Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J Exp Med (1989) 1.18
Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood (2001) 1.18
Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res (1998) 1.17
The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis (2009) 1.15
Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem (1995) 1.15
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
An assay for the quantitative measurement of in vitro phagocytosis of early apoptotic thymocytes by murine resident peritoneal macrophages. J Immunol Methods (1999) 1.13
Heparanase in glomerular diseases. Kidney Int (2007) 1.13
Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am J Pathol (2000) 1.13
Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol (2000) 1.12
Increased expression of heparanase in overt diabetic nephropathy. Kidney Int (2006) 1.11
Incomplete nuclear transformation of human spermatozoa in oligo-astheno-teratospermia: characterization by indirect immunofluorescence of chromatin and thiol status. Hum Reprod (2007) 1.11
Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum (1990) 1.11
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) (2001) 1.10
Decreased PMN accumulation and glomerular damage by clodronate liposome treatment in PMN-dependent anti-GBM nephritis in mice. Exp Nephrol (1997) 1.10
Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase. Virchows Arch A Pathol Anat Histopathol (1985) 1.09
Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum (1987) 1.08
The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods (1990) 1.08
The localization of histone H3.3 in germ line chromatin of Drosophila males as established with a histone H3.3-specific antiserum. Chromosoma (1997) 1.08
Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int (1996) 1.08
Dissociation of DNA/anti-DNA complexes at high pH. Immunol Commun (1980) 1.07
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.07
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford) (1999) 1.06
Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int (2007) 1.05
Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: effects of pre-treatment with cobra venom factor and anti-lymphocyte serum. Clin Exp Immunol (1984) 1.05
Reactive arthritis after Campylobacter jejuni enteritis. J Rheumatol (1980) 1.05
A sensitive haemolytic assay of mouse complement. J Immunol Methods (1978) 1.05
Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase. Kidney Int (1990) 1.04
6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol (1993) 1.03
Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem (1998) 1.02
A comparative study of total body irradiation as a method of inducing granulocyte depletion in mice. J Immunol Methods (1984) 1.02
Airway inflammation and remodeling in two mouse models of asthma: comparison of males and females. Int Arch Allergy Immunol (2010) 1.02
Membranous glomerulonephritis in the mouse. Kidney Int (1983) 1.01
Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. Kidney Int (2007) 1.00
In vivo ANA is a fixation artifact: nucleosome-complexed antinucleosome autoantibodies bind to the cell surface and are internalized. J Am Soc Nephrol (1996) 1.00
Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis Rheum (2001) 1.00
Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis (1989) 1.00